- Home
- Signaling Pathways
- Ubiquitination/ Proteasome
- Autophagy
- Divalproex Sodium
- Home
- Biochemical Reagent
- Anti-infection
- Divalproex Sodium
- Home
- Biochemical Reagent
- Signaling pathways
- Metabolic Enzyme
- Protease
- Divalproex Sodium
- Home
- Biochemical Reagent
- Signaling pathways
- Apoptosis
- Autophagy
- Divalproex Sodium
- Home
- Biochemical Reagent
- Signaling pathways
- Cell Cycle
- DNA Damage
- Divalproex Sodium
- Home
- Biochemical Reagent
- Signaling pathways
- Epigenetics
- Divalproex Sodium
- Home
- Biochemical Reagent
- Signaling pathways
- Neuroscience
- Divalproex Sodium
- Home
- Biochemical Reagent
- Signaling pathways
- Stem Cell
- Wnt
- Divalproex Sodium
Divalproex Sodium
Catalog No.
B1391
Epilepsy/migraines/bipolar disorder medicine
Featured Products
Divalproex sodium (USAN) consists of a compound of sodium valproate and valproic acid in a 1:1 molar relationship in an enteric coated form.[1] Its chief use in medicine is as a treatment for bipolar disorder, epilepsy and in the prevention of migraines.
Physical Appearance | A solid |
Storage | Store at -20°C |
M.Wt | 310.41 |
Cas No. | 76584-70-8 |
Formula | C8H16O2·C8H15O2·Na |
Solubility | ≥14.2 mg/mL in DMSO; ≥23.9 mg/mL in H2O; ≥29.55 mg/mL in EtOH |
Chemical Name | sodium;2-propylpentanoate;2-propylpentanoic acid |
SDF | Download SDF |
Canonical SMILES | CCCC(CCC)C(=O)O.CCCC(CCC)C(=O)[O-].[Na+] |
Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
General tips | We do not recommend long-term storage for the solution, please use it up soon. |
Quality Control & MSDS
- View current batch:
Chemical structure
